Skip to content
healthcare.dev

Icatibant

NDC 62332-654, Icatibant, injection, from Alembic Pharmaceuticals Inc..

Product NDC
62332-654
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213773
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-654 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ICATIBANT ACETATE30 mg/3mL

Pharmacologic classes

Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]

Package NDCNDC-11Package
62332-654-03623320654031 SYRINGE, GLASS in 1 CARTON (62332-654-03) / 3 mL in 1 SYRINGE, GLASS
62332-654-09623320654093 SYRINGE, GLASS in 1 CARTON (62332-654-09) / 3 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aeb5406c-9501-4f43-8134-5b02a7fa7451

Use it

Look up 62332-654 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-654 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-654. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.